Johnson & Johnson & Ethicon Transvaginal Mesh Case — Update

Johnson & Johnson & Ethicon Transvaginal Mesh Case — Update

In April of 2018, an Indiana jury found Johnson & Johnson and Ethicon, a subsidiary of Johnson & Johnson, liable to Barbara Kaiser, an Indiana native, for injuries sustained after Barbara was implanted with the Prolift transvaginal mesh, a product of Johnson & Johnson, and experienced severe discomfort, pain, and injuries. Aside from such discomfort and pain, she specifically experienced “permanent injury that required corrective surgery after her doctor implanted her” with the transvaginal mesh.

A transvaginal mesh, or pelvic mesh, is an implant used to treat pelvic organ prolapse and stress urinary incontinence in women.

The jury found Johnson & Johnson and Ethicon to be negligent in the design and marketing (misleading the general public about the risks involved) of the pelvic mesh and found them liable for $10 million in compensatory damages and $25 million in punitive damages. An Indiana federal judge brought down the punitive damages amount to $10 million. Barbara Kaiser will receive $20 million in compensatory and punitive damages.

Barbara, and her husband Anton, sought the expert legal help of Thomas O. Plouff, (Of Counsel to Costello, McMahon, Burke & Murphy, LTD, Chicago)  Plouff stated:

Ethicon defended an indefensible product and the jury stood up for Barb Kaiser. We thank them for their service.  We are thrilled to help a remarkable woman  who suffered at the hands of a corporation who put profits over patient safety.

0

Related Posts

How to thread the…

Often plaintiff attorneys decide on medical device cases by taking ones where the FDA has not made a safety and efficacy determination under 510(k), and declining cases where the device…
Read more

Safe Medical Devices and…

FDA Commissioner Scott Gottlieb recently emphasized that “the most impactful way that we can promote innovation and improved safety in the 510(k) program is to drive innovators toward reliance on…
Read more

Transvaginal Mesh and the…

The Food and Drug Administration (FDA) Commissioner Scott Gottlieb first announced the agency would meet on surgical mesh safety and effectiveness of transvaginal pelvic organ prolapse repair in a statement…
Read more